Sources | Names Used |
---|---|
CTRPv2 | BRD-K66453893 |
PharmacoGx | BRD-K66453893 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAF5 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-11 |
mRNA | BCL2L1 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-10 |
mRNA | CD63 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-10 |
mRNA | SMARCC1 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | NASP | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | ANP32E | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
mRNA | GMEB1 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
mRNA | RP11-426L16.10 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-09 |